MedPath

Repetitive transcranial stimulation (rTMS) in Treatment resistant obsessive compulsive disorder

Not Applicable
Conditions
Health Condition 1: F422- Mixed obsessional thoughts and acts
Registration Number
CTRI/2023/01/048707
Lead Sponsor
Dr Kartikeya R Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of either sex aged between 18 to 60 years.

Diagnosed cases of treatment resistant Obsessive compulsive disorder. Normotensive patients.

Age range:- 18- 60 years

Patients who gave written informed consent.

Exclusion Criteria

Patients unwilling to participate in the study or dropped out during study period.

Current neurological or any comorbid psychiatric disorder.

History of epilepsy, significant head injury, drug abuse or any neurosurgical procedure, hypertension.

Subjects positive for TMS Adult Safety Screen (TASS) including individuals with cardiac pacemaker or metal in head.

Subjects who received ECT (Electro Convulsive Therapy) or antipsychotics in past 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the efficacy of rTMS (Repetitive transcranial magnetic stimulation) as an adjunctive treatment modality in patients of treatment resistant OCD (Obsessive Compulsive Disorder <br/ ><br>Timepoint: Baseline and 2 weeks <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To compare the efficacy of active low frequency rTMS as an adjunctive treatment with the sham rTMS in cases of treatment resistant OCDTimepoint: To compare the efficacy of active low frequency rTMS as an adjunctive treatment with the sham rTMS in cases of treatment resistant OCD after 2 weeks
© Copyright 2025. All Rights Reserved by MedPath